Mount Sinai’s Distinguished History of Transplant Medicine

Mount Sinai Health System is known internationally for its innovation in research, education, and clinical care. The Recanati/Miller Transplantation Institute (RMTI) at Mount Sinai is one of the nation’s leading academic transplant centers providing comprehensive care to those with end stage organ failure.

Mount Sinai’s transplant program began in 1967, as one of the first in the northeast. We have been performing pancreas transplants since 1994, and we performed our first laparoscopic kidney transplant in 1996. Our liver transplant program began in 1988 when the founders, Charles Miller, MD, and Myron Schwartz, MD, performed the first liver transplant in New York State. In 1993, we performed the first pediatric live donor transplant in the state, and in 1998 the first adult-to-adult living donor liver transplant.

Our clinical expertise in the care of patients with end stage organ failure is insurmountable. RMTI researchers are constantly working independently and collaboratively to improve organ preservation, reduce rejection, minimize surgical complications, and improve long-term survival of transplant recipients.

Calling on our many years of experience, the RMTI team is committed to providing lifelong partnership with our patients, their families, and referring physicians. Our mission is to provide exemplary medical and surgical care in a compassionate and individualized setting, a hallmark of the RMTI.